Surgical outcomes of low-power thulium laser enucleation of prostates >80 g. One-year of follow-up.

ABSTRACT:

Introduction

The aim of this study was to assess the effectiveness of low-power thulium (30 W) and the duration necessary to eliminate adenomas at the level of the surgical capsule, as well as its impact on postoperative urinary and sexual function.

Material and methods

Patients with symptomatic benign prostatic hyperplasia (BPH), who had ThuLEP between December 2019 and March 2022 and had a prostate size >80 mL and had not responded to the medication therapy, were included. The prostate size, prostate-specific antigen (PSA), enucleation and morcellation times, postoperative International Prostate Symptom Score (IPSS), and International Index of Erectile Function-5 (IEFF-5) records at 1, 3, 6, and 12 months were among the information gathered.

Results

The average age

SUBMITTER: Morsy S 

PROVIDER: S-EPMC10690385 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature